Dublin, March 15, 2017 (GLOBE NEWSWIRE) -- Research and Markets has announced the addition of the "Biosurgery: Technologies and Global Markets" report to their offering.
The Global Biosurgery Market Should Reach $12.5 Billion by 2021 from $8.3 Billion in 2016 at a CAGR of 8.5%
This report analyzes the market for products used to reduce excessive hemorrhage during surgery. In a surgical procedure, these products are used as adhesion agents to seal wounds and to repair damaged or weakened tissue.
Due to their ease of application, these products improve the work efficiency of surgeons. Biosurgery products can be used to disinfect wounds with the help of maggots, and are used particularly for chronic infected wounds, which do not get treated by antibiotics. This report covers all of the existing applications of biosurgery products.
The global biosurgery market is segmented primarily by product type, application, source, and region. Biosurgery products are segmented by type into anti-adhesive agents, hemostatic agents, surgical sealing agents, bone-graft substitutes, and soft-tissue management. The application segments include cardiothoracic surgery, neurosurgery and spine surgery, orthopedic surgery, and general surgery. Based on source, the biosurgery market is segmented into biological and synthetic products.
An in-depth analysis of these segments is given in this report. The report also provides a detailed qualitative account of the market dynamics, technology trends, key strategies, and regulatory scenario.
Report Includes:
- An overview of the global market for biosurgery.
- Analyses of global market trends, with data from 2015 and 2016, and projections of compound annual growth rates (CAGRs) through 2021.
- Segmentation of the market on the basis of product type, source, application, and region.
- In depth coverage of the market dynamics, technology trends, drivers, constraints, and key strategies.
- Discussion of government regulations, medical associations & international regulatory agencies.
- Analysis of patents pertaining to biosurgery.
- Profiles of companies related to the industry.
Key Topics Covered:
1: Introduction
- Study Objectives
- Scope Of Report
- Intended Audience
- Source Of Information And Methodology
2: Executive Summary
3: Market Overview
- Market Evolution And Innovation
- Government Regulations, Medical Associations, And International Regulatory Agencies
- Demographics, Incidence And Prevalence Rates, And Other Factors Influencing Biosurgery Market Growth
- Clinical Guidelines And Reimbursement Scenario
- Technology Trends
- Biosurgery Pipeline
- Novel Technologies For The Future Of Biosurgery
- Key Strategies
- Market Dynamics
4: Biosurgery Market By Product Type
- Anti-Adhesive Agents
- Hemostatic Agents
- Surgical Sealing Agents
- Bone-Graft Substitutes
- Soft-Tissue Management/Mesh/Patch
5: Biosurgery Market By Application
- Cardiothoracic Surgery
- Neurosurgery And Spine Surgery
- Orthopedic Surgery
- General Surgery
- Incidence Rates Of Surgical Procedures And Analysis
6: Biosurgery Market By Source
- Natural/Biological Products
- Synthetic Products
7: Competitive Landscape
- Product Development
- Agreement
- Acquisition
- Expansion
8: Biosurgery Market By Region
- North America
- Europe
- Asia-Pacific
- Rest Of World
9: Patent Analysis
- U.S. Patent Analysis
- Europe Patent Analysis
- Japan Patent Analysis
- China Patent Analysis
- Korea Patent Analysis
10: Company Profiles
- B. Braun Melsungen AG
- Baxter International Inc.
- Cerapedics Inc.
- Cohera Medical Inc.
- C.R. Bard Inc.
- Cryolife Inc.
- Exactech Inc.
- Hemostasis Llc
- Hyperbranch Medical Technology Inc.
- Johnson & Johnson
- Kuros Biosciences AG
- Medtronic Plc
- Rti Surgical
- Sanofi SA
- Smith & Nephew Plc
- Stryker Corp.
- Tissuemed Ltd.
- Wright Medical Group NV
- Z-Medica Corp.
- Zimmer Biomet Holdings Inc.
11: Appendix
For more information about this report visit http://www.researchandmarkets.com/research/r95k3x/biosurgery